Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com cut shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Thursday. CDXS has been the subject of several other reports. Stifel Nicolaus reduced their price objective on Codexis from $9.00 to $5.00 and set a buy rating for the company […]
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday. CDXS has been the subject of several other reports. Benchmark restated a buy rating and set a $9.00 price target on shares of Codexis in a research report on […]
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a sell rating to a hold rating in a research report released on Wednesday morning. A number of other equities analysts have also weighed in on CDXS. TD Cowen lowered Codexis from an outperform rating to a market perform rating and lowered their target price […]
REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President...